19 December 2022 - Medicines Australia welcomes the latest peer-reviewed research paper indicating the rollout of the COVID-19 vaccinations significantly reduced the economic impact of the pandemic.
CEO of Medicines Australia, Elizabeth de Somer said the paper – titled The Value of Vaccines: A Tale of Two Parts in Vaccines – demonstrates the benefit of fast access to medical innovations and points to the need for reform to our medicines assessment system so we are prepared for the next health challenges.